1 April 2023 in Nature Communications
While experimental and informatic techniques around single cell sequencing (scRNA-seq) are advanced, research around mass cytometry (CyTOF) data analysis has severely lagged behind. CyTOF data are notably different from scRNA-seq data in many aspects. This calls for the evaluation and development of computational methods specific for CyTOF data. Dimension reduction (DR) is one of the critical steps of single cell data analysis. Here, we benchmark the performances of 21 DR methods on 110 real and 425 synthetic CyTOF samples. We find that less well-known methods like SAUCIE, SQuaD-MDS, and scvis are the overall best performers. In particular, SAUCIE and scvis are well balanced, SQuaD-MDS excels at structure preservation, whereas UMAP has great downstream analysis performance. We also find that t-SNE (along with SQuad-MDS/t-SNE Hybrid) possesses the best local structure preservation. Nevertheless, there is a high level of complementarity between these tools, so the choice of method should depend on the underlying data structure and the analytical needs.
4 May 2026 in Nature Communications
With the rise of large-scale genomic studies, large gene lists targeting important diseases are increasingly common. While evaluating each study individually gives valuable insights on specific samples and study designs, the wealth of available evidence in the literature calls for robust and efficient meta-analytic methods. Crucially, the diverse assumptions and experimental protocols underlying different studies require a flexible but rigorous method for aggregation. To address these issues, we propose BiGER, a Bayesian rank aggregation method for the inference of latent global rankings. Unlike existing methods in the field, BiGER accommodates mixed gene lists with top-ranked and top-unranked genes as well as bottom-tied and missing genes, by design. Using a Bayesian hierarchical framework combined with variational inference, BiGER efficiently aggregates large-scale gene lists, consistently achieving state-of-the-art accuracy, while providing valuable insights into source-specific reliability for researchers. Through both simulated and real datasets, we show that BiGER is a useful tool for reliable meta-analysis in genomic studies.
8 April 2024 in Nature Communications